APA
HALO icon

American Portfolios Advisors’s Halozyme HALO Stock Holding History

American Portfolios Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$45.4K – 3504
2021
Q2 		$45.4K Buy
+1,000
New +$44.3K ﹤0.01% 1775

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Portfolios Advisors's HALO Position: Q3 2021 in Review

American Portfolios Advisors sold out of Halozyme (HALO) in Q3 2021, closing a stake of 1,000 shares — an estimated $45.4K sold.

American Portfolios Advisors first reported a position in HALO in Q2 2021 and held it in 1 quarter. The position peaked at $45.4K in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q3 2021.

  • American Portfolios Advisors reported no remaining Halozyme position as of Q3 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 1,000 Halozyme shares in Q3 2021, an estimated $45.4K.
  • American Portfolios Advisors first reported a position in Halozyme in Q2 2021 and held it in 1 quarter.
  • American Portfolios Advisors's Halozyme position peaked at $45.4K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Halozyme as of Q3 2021.

Based on American Portfolios Advisors's 13F filing for Q3 2021, filed 22 Mar 2023.